Filter
307
Filtered Results: 307
Text search:
University
of
California
San
Francisco
Featured
Recommendations
33
New Publications
50
Language
Document type
No document type
141
Studies & Reports
64
Guidelines
51
Manuals
29
Strategic & Response Plan
10
Training Material
6
Fact sheets
2
Brochures
1
Situation Updates
1
App
1
Resource Platforms
1
Countries / Regions
Global
17
Latin America and the Carribbean
7
Kenya
5
Tanzania
4
Zambia
4
India
4
Ukraine
3
Ghana
3
Zimbabwe
3
Africa
3
Uganda
3
Russia
3
Afghanistan
2
USA
2
Haiti
2
North America
2
Botswana
2
Tajikistan
1
Mexico
1
Albania
1
Philippines
1
Asia
1
Venezuela
1
Germany
1
West and Central Africa
1
Western and Central Europe
1
France
1
Argentina
1
Bangladesh
1
South Africa
1
Eastern Europe
1
Brazil
1
Namibia
1
Mali
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
60
Countries
45
Women & Child Health
21
Public Health
14
Key Resources
9
Pharmacy & Technologies
5
Capacity Building
3
Toolboxes
HIV
79
TB
43
Planetary Health
27
NTDs
15
Mental Health
14
COVID-19
12
Caregiver
12
Malaria
11
Global Health Education
8
Disability
5
Health Financing Toolbox
5
Rapid Response
4
Refugee
4
Pharmacy
3
Natural Hazards
2
Ebola & Marburg
2
Social Ethics
1
NCDs
1
Conflict
1
Zika
1
Polio
1
AMR
1
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
WHO's Health in the Green Economy sector briefings examine the health impacts of climate change mitigation strategies considered by the Intergovernmental Panel on Climate Change in their Fourth Assessment Report (Climate Change, 2007). Large, immediate health benefits from some climate change strate...
The Planetary Health Report Card is a student-driven, metric-based initiative to inspire planetary health and sustainable healthcare education engagement in medical schools. In addition to inspiring expansion of medical school curricula, we hope to inspire medical schools to expand research efforts,...
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
Rreport of a WHO Consultative Meeting Kolkata India 2012
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Examples of small-scale disinfection products for safe drinking water
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
WHO guideline on health policy and system support to optimize community health worker programmes
recommended
The guideline uses state-of-the-art evidence to identify effective policy options to strengthen community health worker (CHW) programme performance through their proper integration in health systems and communities.
Successful delivery of services through CHWs requires evidence-based models for edu...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
SAHARA-J: Journal
of Social Aspects of HIV/AIDS, 13:1, 1-7, DOI: 10.1080/17290376.2015.1123646
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
Despite recent global declines, under-five mortality remains high in many of the poorest countries. Barriers to timely
quality care, including user fees, distance to facilities and the availability of trained health workers and medical supplies,
hinder progress in further reducing morbidity and m...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
